Cash · 2016–2025
Kiniksa Pharmaceuticals International cash
$166M−9.8% · FY2025
Kiniksa Pharmaceuticals International (KNSA) reported $166M in cash for fiscal 2025, −9.8% year on year.
| Fiscal year | Cash | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $166M | −9.8% | Open → |
| FY20242024-12-31 | $184M | +70.1% | Open → |
| FY20232023-12-31 | $108M | −12.0% | Open → |
| FY20222022-12-31 | $123M | +0.2% | Open → |
| FY20212021-12-31 | $122M | +7.4% | Open → |
| FY20202020-12-31 | $114M | +143.0% | Open → |
| FY20192019-12-31 | $46.9M | −34.8% | Open → |
| FY20182018-12-31 | $72.0M | +58.0% | Open → |
| FY20172017-12-31 | $45.6M | −18.8% | Open → |
| FY20162016-12-31 | $56.1M | — | Open → |
Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2016–2025 compound annual growth +12.8%
Cash at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Kiniksa Pharmaceuticals International cash |url=https://companiesranked.com/en/company/kiniksa-pharmaceuticals-international/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Kiniksa Pharmaceuticals International cash. CompaniesRanked. https://companiesranked.com/en/company/kiniksa-pharmaceuticals-international/cash-on-handBibTeX
@misc{companiesranked-en-company-kiniksa-pharmaceuticals-international-cash-on-hand-2026,
author = {{CompaniesRanked}},
title = {{Kiniksa Pharmaceuticals International cash}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/kiniksa-pharmaceuticals-international/cash-on-hand}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001104659-26-087545 · July 28, 2026
{{cite web |title=Kiniksa Pharmaceuticals International cash — 10-Q (0001104659-26-087545) |url=https://www.sec.gov/Archives/edgar/data/1730430/000110465926087545/knsa-20260630x10q.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-07-28}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.